Macrolide Antibiotic Comparison

Introduction to Macrolide Selection

• The Centers for Disease Control and Prevention recommends clarithromycin over erythromycin for most clinical applications due to better tolerability, simpler dosing, and equivalent efficacy 1, 2

Pharmacokinetic Considerations

• Clarithromycin requires only twice-daily administration versus erythromycin's four-times-daily dosing, substantially improving compliance 1, 2
• The treatment duration for pertussis is 7 days for clarithromycin and 14 days for erythromycin due to reported relapses after shorter courses 1, 2

Efficacy and Tolerability

• Clarithromycin is significantly more effective than erythromycin for symptom control and endoscopic improvement in chronic rhinosinusitis 3, 4
• Gastrointestinal adverse events are significantly more frequent and severe with erythromycin than with clarithromycin 1, 2, 5

Safety Considerations

• Both erythromycin and clarithromycin are associated with QT/QTc interval prolongation, cardiac arrest, torsades de pointes, and ventricular arrhythmias, and should not be used with astemizole, cisapride, pimozide, or terfenadine 1, 2, 3, 4
• Erythromycin is strongly associated with infantile hypertrophic pyloric stenosis in infants <1 month and should be avoided in this age group 1, 5

Drug Interactions

• Both erythromycin and clarithromycin are potent CYP3A4 inhibitors with extensive interaction potential, and should not be used with HMG-CoA reductase inhibitors metabolized by CYP3A4, colchicine, ticagrelor, or ranolazine 1, 2, 3, 4

Pregnancy and Lactation

• Erythromycin is categorized as pregnancy category B, while clarithromycin is categorized as pregnancy category C 1, 2

Dosing Considerations

• Clarithromycin can be administered without dosage adjustment in patients with hepatic impairment if renal function is normal 1, 2
• Clarithromycin requires dosage adjustment when creatinine clearance <1.8 L/h (approximately <30 mL/min) 1, 2

Clinical Decision-Making

• The American Academy of Pediatrics and the Centers for Disease Control and Prevention recommend choosing clarithromycin over erythromycin when treating community-acquired respiratory infections in adults or children >1 month 1, 2
• Azithromycin is the preferred macrolide for neonates when treatment is necessary, and for patients taking multiple CYP3A4-metabolized medications 5, 6, 7, 8, 9